Quick Takeaways
- CITADEL ADVISORS LLC filed SCHEDULE 13G for Cullinan Therapeutics, Inc. Common Stock, par value $0.0001 per share (the "Shares") (CGEM).
- Disclosed ownership: 5.1%.
- Date of event: 30 Jul 2025.
Quoteable Key Fact
"CITADEL ADVISORS LLC disclosed 5.1% ownership in Cullinan Therapeutics, Inc. Common Stock, par value $0.0001 per share (the "Shares") (CGEM) on 30 Jul 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Citadel Advisors LLC | 4.3% | 2,511,191 | 0 | 2,511,191 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Advisors Holdings LP | 4.3% | 2,511,191 | 0 | 2,511,191 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel GP LLC | 4.3% | 2,511,191 | 0 | 2,511,191 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Securities LLC | 0.8% | 497,935 | 0 | 497,935 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Securities Group LP | 0.8% | 497,935 | 0 | 497,935 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Securities GP LLC | 0.8% | 497,935 | 0 | 497,935 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Kenneth Griffin | 5.1% | 3,009,126 | 0 | 3,009,126 | /s/ Seth Levy | Seth Levy, attorney-in-fact* |